P
Pfizer
Biotech & Life Sciences · New York City, United States · Founded 1849 · IPO 1983
Prescription medicines, vaccines and consumer products MoreLess
Pfizer Inc. is a leading biopharmaceutical company that focuses on the discovery, development, and manufacture of healthcare products. Operating in the global healthcare market, Pfizer serves a diverse range of clients including governments, healthcare providers, and patients. The company’s business model revolves around the research and development of innovative medicines and vaccines, which are then commercialized and distributed worldwide. Pfizer generates revenue through the sale of its pharmaceutical products, which include vaccines, oncology treatments, and other specialized medicines. The company has been at the forefront of the fight against COVID-19, partnering with BioNTech to develop and distribute a highly effective vaccine. Pfizer's commitment to public health is further demonstrated by its initiatives to provide vaccines to underserved populations. The company continues to expand its portfolio with new approvals and authorizations for various treatments, ensuring a steady pipeline of future products.
Keywords: biopharmaceutical, vaccines, oncology, healthcare, global market, innovation, COVID-19, BioNTech, public health, research and development.
Talent graph
Pfizer's talent
Source: Dealroom Talent Intelligence.
Investors
2 investors on Pfizer's cap table
Sourced from Dealroom's funding history.


Global footprint
Where Pfizer has talent and traffic
Market sentiment
What the market is saying about Pfizer
An AI-synthesized read of the highest-engagement posts about Pfizer on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pfizer on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.